Epidemiology of Community-Acquired Sepsis in Adult Patients: A Six Year Observational Study


Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host response to an infection and it is a major cause of morbidity and mortality worldwide. The aim of this study is to describe epidemiology of community-acquired sepsis in the Intensive care unit (ICU) of the Macedonian tertiary care University Clinic for Infectious Diseases. A prospective observational study was conducted over a 6-year period from January, 2011 to December, 2016. All consecutive adults with community-acquired sepsis or septic shock were included in the study. Variables measured were incidence of sepsis, age, gender, comorbidities, season, source of infection, complications, interventions, severity indexes, length of stay, laboratory findings, blood cultures, 28-day and in hospital mortality. Of 1348 admissions, 277 (20.5%) had sepsis and septic shock. The most common chronic condition was heart failure (26.4%), and the most frequent site of infection was the respiratory tract (57.4%). Median Simplified Acute Physiology Score (SAPS II) was 50.0, and median Sequential Organ Failure Assessment (SOFA) score was 8.0. Blood cultures were positive in 22% of the cases. Gram-positive bacteria were isolated in 13% and Gram-negatives in 9.7% of patients with sepsis. The overall 28-day and in hospital mortality was 50.5% and 56.3% respectively. The presence of chronic heart failure, occurrence of ARDS, septic shock and the winter period may influence an unfavorable outcome. Mortality compared to previous years is unchanged but patients that we have been treating these last 6 years have had more severe illnesses. Better adherence to the Surviving Sepsis guidelines will reduce mortality in this group of severely ill patients.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • 1. Singer M, Deutschman C, Seymour C, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA 2016; 315: 801-10.

  • 2. Linde-Zwirble WT, Angus DC. Severe sepsis epidemiology: Sampling, selection, and society. Crit Care 2004; 8: 222-6.

  • 3. Angus DC, Linde-Zwirble WT, Lidicker J, et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Critical care medicine 2001; 29(7): 1303-1310.

  • 4. Henriksen DP, Laursen CB, Jensen TG, et al Incidence Rate of Community-Acquired Sepsis Among Hospitalized Acute Medical Patients – A Population-Based Survey. Crit Care Med 2015; 43: 13-21.

  • 5. Mayr FB, Yende S, Angus DC. Epidemiology of severe sepsis. Virulence 2014; 5(1): 4–11.

  • 6. Moerer O, Plock E, Mgbor U, et al. A German national prevalence study on the cost of intensive care: an evaluation from 51 intensive care units. Crit Care 2007; 11(3): R69.

  • 7. Martin GS. Sepsis, severe sepsis and septic shock: changes in incidence, pathogens and outcomes. Expert Rev Anti-Infect Ther 2012; 10(6): 701-6.

  • 8. Ferrer R, Artigas A, Levy MM, et al. Improvement in process of care and outcome after a multicenter severe sepsis educational program in Spain. JAMA 2008; 299(19): 2294-303.

  • 9. Vincent JL, Rello J, Marshall J, et al. International study of the prevalence and outcomes in infection in intensive care units. JAMA 2009; 302: 2323-9.

  • 10. Ranieri VM, Rubenfeld GD, Thompson BT, et al. ARDS Definition Task Force. Acute respiratory distress syndrome: the Berlin definition. JAMA 2012; 307: 2526–2533.

  • 11. Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996; 22(7): 707–10.

  • 12. Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993; 270: 2957–2963.

  • 13. Shankar-Hari M, Harrison DA, Rubenfeld GD, Rowan K. Epidemiology of sepsis and septic shock in critical care units: comparison between sepsis-2 and sepsis-3 populations using a national critical care database. Br J Anaesth 2017; 119(4): 626–636.

  • 14. Ogura H, Gando S, Saitoh D, et al. Epidemiology of severe sepsis in Japanese intensive care units: a prospective multicenter study. J Infect Chemother 2014; 20: 157–162.

  • 15. Brun-Buisson C, Meshaka P, Pinton P, et al. EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units. Intensive Care Med 2004; 30: 580–588.

  • 16. Padkin A, Goldfrad C, Brady AR, et al. Epidemiology of severe sepsis occurring in the first 24 hrs in intensive care units in England, Wales, and Northern Ireland. Crit Care Med 2003; 31: 2332–2338.

  • 17. J. Zhou, C. Qian, M. Zhao, et al. Epidemiology and outcome of severe sepsis and septic shock in intensive care units in mainland China. PLoS One 2014; 9(9); p. e107181.

  • 18. Warmerdam M, Stolwijk F, Boogert A, et al. Initial disease severity and quality of care of emergency department sepsis patients who are older or younger than 70 years of age. PLoS One 2017; 12(9): e0185214.

  • 19. Danai PA, Sinha S, Moss M, et al. Seasonal variation in the epidemiology of sepsis. Critical care medicine 2007; 35(2): 410–415.

  • 20. Mikkelsen ME, Shah CV, Meyer NJ, et al. The epidemiology of acute respiratory distress syndrome in patients presenting to the emergency department with severe sepsis. Shock Augusta Ga 2013; 40(5): 375–381.

  • 21. Kim W-Y, Hong S-B. Sepsis and Acute Respiratory Distress Syndrome: Recent Update. Tuberc Respir Dis (Seoul) 2016; 79(2): 53–7.

  • 22. ARDSnet Investigators. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000; 342: 1301–8.

  • 23. Todi S, Chatterjee S, Bhattacharyya M. Epidemiology of severe sepsis in India. Crit Care 2007; 11(Suppl 2): 65.

  • 24. Dabhi AS, Khedekar SS, Mehalingam V. A Prospective Study of Comparison of APACHE-IV & SAPS-II Scoring Systems and Calculation of Standardised Mortality Rate in Severe Sepsis and Septic Shock Patients. Journal of Clinical and Diagnostic Research : JCDR 2014;8(10):MC09-MC13.

  • 25. Lee JH, Kim J, Kim K, et al. Albumin and C-reactive protein have prognostic significance in patients with community-acquired pneumonia. J Crit Care 2011; 26: 287-94.

  • 26. Artero A, Zaragoza R, Camarena JJ, et al. Prognostic factors of mortality in patients with community-acquired bloodstream infection with severe sepsis and septic shock. J Crit Care 2010; 25: 276-81.

  • 27. Seo MH, Choa M, You JS, et al. Hypoalbuminemia, Low Base Excess Values, and Tachypnea Predict 28-Day Mortality in Severe Sepsis and Septic Shock Patients in the Emergency Department. Yonsei Medical Journal 2016; 57(6): 1361-1369.

  • 28. Kojic D, Siegler BH, Uhle F, et al. Are there new approaches for diagnosis, therapy guidance and outcome prediction of sepsis? World J Exp Med 2015; 5(2): 50–63.

  • 29. Ogura H, Gando S, Saitoh D, et al. Epidemiology of severe sepsis in Japanese intensive care units: a prospective multicenter study. J Infect Chemother 2014; 20: 157–162.

  • 30. Kempker JA, Martin GS. The changing epidemiology and definitions of sepsis. Clin Chest Med 2016; 37: 165–79.

  • 31. Bouza C, Lopez-Cuadrado T, Saz-Parkinson Z, et al. Epidemiology and recent trends of severe sepsis in Spain: a nationwide population-based analysis (2006–2011) BMC Infect Dis 2014; 14: 3863.

  • 32. Baharoon S, Telmesani A, Tamim H, et al. Community-versus nosocomial-acquired severe sepsis and septic shock in patients admitted to a tertiary intensive care in Saudi Arabia, etiology and outcome. J Infect Public Health 2015; 8(5): 418-24.

  • 33. Seymour CW, Gesten F, Prescott HC, et al. Time to treatment and mortality during mandated emergency care for sepsis. N Engl J Med 2017; 376(23): 2235–2244.

  • 34. Angus DC, van der Poll T: Severe sepsis and septic shock. N Engl J Med 2013; 369: 2063.

  • 35. De Prost N, Razazi K, Brun-Buisson C. Unrevealing culture-negative severe sepsis. Critical Care. 2013; 17(5): 1001.

  • 36. Grozdanovski K, Milenkovic Z, Demiri I, et al. Prediction of outcome from community-acquired severe sepsis and septic shock in tertiary-care university hospital in a developing country. Critical care research and practice 2012; 2012: 182324.

  • 37. Fleischmann C, Thomas-Rueddel DO, et al. Hospital Incidence and Mortality Rates of Sepsis. Dtsch Arztebl Int 2016; 113(10): 159–66.

  • 38. Rhodes A, Evans LE, Alhazzani W, et al. Surviving Sepsis campaign: international guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Med 2017; 43: 304–377.

  • 39. Pro CI, Yealy DM, Kellum JA, et al. A randomized trial of protocol-based care for early septic shock. N Engl J Med 2014; 370(18): 1683–93.

  • 40. The ARISE Investigators. the ANZICS Clinical Trial Group. Peake SL, Delaney A, Bailey M, et al. Goal-directed resuscitation for patients with early septic shock. N Engl J Med 2014; 371(16): 1496–1506.


Journal + Issues